Why #WeAreNotWaiting–motivations and self-reported outcomes among users of open-source automated insulin delivery systems: multinational survey
Open accessPublished version of a preprint
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Background: Automated insulin delivery (AID) systems have been shown to be safe and effective in reducing hyperglycemia and hypoglycemia but are not universally available, accessible, or affordable. Therefore, user-driven open-source AID systems are becoming increasingly popular. Objective: This study aims to investigate the motivations for which people with diabetes (types 1, 2, and other) or their caregivers decide to build and use a personalized open-source AID. Methods: A cross-sectional web-based survey was conducted to assess personal motivations and associated self-reported clinical outcomes. Results: Of 897 participants from 35 countries, 80.5% (722) were adults with diabetes and 19.5% (175) were caregivers of children with diabetes. Primary motivations to commence open-source AID included improving glycemic outcomes (476/509 adults, 93.5%, and 95/100 caregivers, 95%), reducing acute (443/508 adults, 87.2%, and 96/100 caregivers, 96%) and long-term (421/505 adults, 83.3%, and 91/100 caregivers, 91%) complication risk, interacting less frequently with diabetes technology (413/509 adults, 81.1%; 86/100 caregivers, 86%), improving their or child’s sleep quality (364/508 adults, 71.6%, and 80/100 caregivers, 80%), increasing their or child’s life expectancy (381/507 adults, 75.1%, and 84/100 caregivers, 84%), lack of commercially available AID systems (359/507 adults, 70.8%, and 79/99 caregivers, 80%), and unachieved therapy goals with available therapy options (348/509 adults, 68.4%, and 69/100 caregivers, 69%). Improving their own sleep quality was an almost universal motivator for caregivers (94/100, 94%). Significant improvements, independent of age and gender, were observed in self-reported glycated hemoglobin (HbA1c), 7.14% (SD 1.13%; 54.5 mmol/mol, SD 12.4) to 6.24% (SD 0.64%; 44.7 mmol/mol, SD 7.0; P<.001), and time in range (62.96%, SD 16.18%, to 80.34%, SD 9.41%; P<.001). Conclusions: These results highlight the unmet needs of people with diabetes, provide new insights into the evolving phenomenon of open-source AID technology, and indicate improved clinical outcomes. This study may inform health care professionals and policy makers about the opportunities provided by open-source AID systems. International Registered Report Identifier (IRRID): RR2-10.2196/15368
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The OpenAPS heuristic algorithm (implemented on a system on a chip in OpenAPS, Android smartphones as An-droidAPS, and iPhone as iAPS/Trio) is supported by large real-world studies (256) and a multicenter RCT (257).”
From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [256]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384 · cited 1×
“Data were collected and managed using secure Research Electronic Data Capture electronic data capture tools hosted at Charité [19].”
Content analysis and thematic analysis: Implications for conducting a qualitative descriptive study
Vaismoradi, M., Turunen, H., & Bondas, T. (2013) · Nursing & Health Sciences · doi:10.1111/nhs.12048 · Cited by 8,327 · cited 1×
“Content analysis was performed to analyze responses to open-ended questions [20].”
Eysenbach, G. (2004) · Journal of Medical Internet Research · doi:10.2196/jmir.6.3.e34 · Cited by 6,480 · cited 1×
“The Checklist for Reporting Results of Internet E-Surveys was used to guide survey development [18].”
Computing Inter-Rater Reliability for Observational Data: An Overview and Tutorial
Hallgren, K. A. (2012) · Tutorials in Quantitative Methods for Psychology · doi:10.20982/tqmp.08.1.p023 · Cited by 3,884 · cited 1×
“The interrater reliability (percentage agreement for multiple raters) method was used to calculate the level of agreement between coders, and the final list of the most frequently discussed codes was generated [21].”
Van Dongen, H. P. A., Maislin, G., Mullington, J. M., & Dinges, D. F. (2003) · Sleep · doi:10.1093/sleep/26.2.117 · Cited by 3,173
Irwin, M. R., Olmstead, R., & Carroll, J. E. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.05.014 · Cited by 2,085 · cited 1×
“Poor quality of sleep negatively affects the psychological well-being, cognitive functioning, and a diverse range of hormones that affect the regulation of appetite and our homeostatic systems as well as the immune system [25-34].”
The glymphatic system: a beginner's guide
Jessen, N. A., Munk, A. S. F., Lundgaard, I., & Nedergaard, M. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1581-6 · Cited by 2,075 · cited 1×
“Recent research also points to sleep as impacting the actual maintenance of the brain and our DNA regenerative systems [35].”
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018
Foster, N. C., Beck, R. W., Miller, K. M., Clements, M. A., Rickels, M. R., DiMeglio, L. A., Maahs, D. M., Tamborlane, W. V., Bergenstal, R., Smith, E., et al. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0384 · Cited by 1,907
Assessment of Diabetes-Related Distress
Polonsky, W. H., Anderson, B. J., Lohrer, P. A., Welch, G., Jacobson, A. M., Aponte, J. E., & Schwartz, C. E. (1995) · Diabetes Care · doi:10.2337/diacare.18.6.754 · Cited by 1,497 · cited 1×
“The complexity of diabetes self-management bears a high cognitive load and can cause distress in everyday life, with approximately 40% of people with type 1 diabetes reporting distress and/or depressive symptoms, particularly prevalent among adolescents and young adults [7-10].”
The Sleep-Immune Crosstalk in Health and Disease
Besedovsky, L., Lange, T., & Haack, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00010.2018 · Cited by 1,479
Cited by
7. Diabetes Technology: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s007 · Cited by 348
de Wit, M., Gajewska, K. A., Goethals, E. R., McDarby, V., Zhao, X., Hapunda, G., Delamater, A. M., & DiMeglio, L. A. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13428 · Cited by 185
“The benefits are more obvious from the emerging evidence on automated insulin delivery systems: these improve clinical outcomes (TIR, HbA1c, reduction in the number of hypoglycemic events),(182,183) and also enhance QOL, reduce diabetes distress, and improve sleep quality in children and caregivers.(184,185) Some psyc…”
BackgroundSelf-citation7. Diabetes Technology: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., ChallaSivaKanaka, S., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s007 · Cited by 279
Braune, K., Lal, R. A., Petruželková, L., Scheiner, G., Winterdijk, P., Schmidt, S., Raimond, L., Hood, K. K., Riddell, M. C., Skinner, T. C., et al. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00267-9 · Cited by 130
Self-citationBiester, T., Berget, C., Boughton, C. K., Cudizio, L., Ekhlaspour, L., Hilliard, M. E., Reddy, L., Sap, S. N. U., Schoelwer, M. J., Sherr, J. L., et al. (2024) · Hormone Research in Paediatrics · doi:10.1159/000543034 · Cited by 124
Speight, J., Choudhary, P., Wilmot, E. G., Hendrieckx, C., Forde, H., Cheung, W. Y., Crabtree, T., Millar, B., Traviss‐Turner, G., Hill, A., et al. (2023) · Diabetic Medicine · doi:10.1111/dme.14944 · Cited by 92
Self-citationCurrent Status and Emerging Options for Automated Insulin Delivery Systems
Forlenza, G. P., & Lal, R. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0514 · Cited by 78
Knoll, C., Peacock, S., Wäldchen, M., Cooper, D., Aulakh, S. K., Raile, K., Hussain, S., & Braune, K. (2021) · Diabetic Medicine · doi:10.1111/dme.14741 · Cited by 67
Self-citationRoos, T., Hermanns, N., Groß, C., Kulzer, B., Haak, T., & Ehrmann, D. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102852 · Cited by 62
“93 Also, Kimbell et al. could con fi rm these fi ndings, as well as less diabetes related distress, less worries of parents of children with diabetes and more normality for them as well as for siblings of the children with diabetes.”
BackgroundAndersen, T. O., Nunes, F., Wilcox, L., Coiera, E., & Rogers, Y. (2023) · ACM Transactions on Computer-Human Interaction · doi:10.1145/3589961 · Cited by 40
Pfiester, E., Braune, K., Thieffry, A., Ballhausen, H., Gajewska, K. A., & O’Donnell, S. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108996 · Cited by 37
Self-citationKnoll, C., Schipp, J., O’Donnell, S., Wäldchen, M., Ballhausen, H., Cleal, B. R., Gajewska, K. A., Raile, K., Skinner, T. C., & Braune, K. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110153 · Cited by 38
Self-citationJansky, B., & Langstrup, H. (2022) · BioSocieties · doi:10.1057/s41292-022-00278-4 · Cited by 39
“Although engaging in this practice demands a lot of determination and mobilization of social and material resources, closing the loop advantages both clinical outcomes (Braune et al. 2021), as well as the quality of life (Schipp et al. 2021).”
BackgroundMethodSelf-citationMewes, D., Wäldchen, M., Knoll, C., Raile, K., & Braune, K. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221080199 · Cited by 31
Self-citationThe first regulatory clearance of an open-source automated insulin delivery algorithm
Braune, K., Hussain, S., & Lal, R. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231164166 · Cited by 23
Self-citationHealthcare 4.0 digital technologies impact on quality of care: a systematic literature review
Marbouh, D., Swarnakar, V., Simsekler, M. C. E., Antony, J., Lizarelli, F. L., Jayaraman, R., Garza‐Reyes, J. A., Shokri, A., Cudney, E. A., & Ellahham, S. H. (2023) · Total Quality Management & Business Excellence · doi:10.1080/14783363.2023.2238629 · Cited by 26
“Highlight the unmet needs of people with chronic diseases (Braune et al., 2021).”
BackgroundPatel, R., Crabtree, T. S. J., Taylor, N., Langeland, L., Gazis, A., Mendis, B., Wilmot, E. G., & IDRIS, I. R. (2022) · Diabetic Medicine · doi:10.1111/dme.14793 · Cited by 23
Jansky, B. (2023) · Science Technology & Human Values · doi:10.1177/01622439231170443 · Cited by 25
“In practice, this means that loopers created an open-source control algorithm that enables an insulin pump and a continuous glucose monitoring device to communicate with each other and thus take over essential data work (Braune et al. 2021).”
BackgroundTornincasa, V., Dixon, D., Masne, Q. L., Martin, B. D., Arnaud, L., van Dommelen, P., & Koledova, E. B. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.882192 · Cited by 23
Braune, K., Krug, N., Knoll, C., Ballhausen, H., Thieffry, A., Chen, Y., O’Donnell, S., Raile, K., & Cleal, B. R. (2021) · Journal of Medical Internet Research · doi:10.2139/ssrn.3946995 · Cited by 19
Self-citationCherubini, V., Faragalli, A., Arnaldi, C., Bassi, M., Bonfanti, R., Bracciolini, G., Cardella, F., Bo, S. D., Delvecchio, M., Candia, F. D., et al. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111621 · Cited by 15
Patient‐reported outcomes in studies of diabetes technology: What matters
Liarakos, A. L., Crabtree, T. S. J., & Wilmot, E. G. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15858 · Cited by 19
O’Donnell, S., Cooper, D., Chen, Y., Ballhausen, H., Lewis, D. M., Froment, T., Gajewska, K. A., Tappe, A., Skinner, T. C., Cleal, B. R., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110235 · Cited by 17
Self-citationHuhndt, A., Chen, Y., O’Donnell, S., Cooper, D., Ballhausen, H., Gajewska, K. A., Froment, T., Wäldchen, M., Lewis, D. M., Raile, K., et al. (2022) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2022.876511 · Cited by 15
Self-citationBukhari, K., & Malek, R. (2021) · BMJ Case Reports · doi:10.1136/bcr-2021-243522 · Cited by 14
Morrison, A., Chong, K., Senior, P. A., & Lam, A. P. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271096 · Cited by 13
“Self-reported user outcomes involved a total of 1508 participants worldwide, with all studies reporting improvements in TIR and/or HbA1c with DIY AID use [5, 33, 36, 40, 47].”
BackgroundMethodInfluentialAutomated insulin dosing systems: Advances after a century of insulin
Thabit, H., Lal, R., & Leelarathna, L. (2021) · Diabetic Medicine · doi:10.1111/dme.14695 · Cited by 14
Mapping the Landscape of Do-it-Yourself Medicine
Wexler, A. (2022) · Citizen Science Theory and Practice · doi:10.5334/cstp.553 · Cited by 14
Wittich, L., Rödiger, H., Rombey, T., Brecher, A.-L., Kraft, L., Sgraja, S., Stein, V. K., & Henschke, C. (2026) · Implementation Science Communications · doi:10.1186/s43058-026-00892-4 · Cited by 22
“In contrast, bottom-up initiatives, shaped by private-sector companies, healthcare providers, and patients [6], often lead to higher user engagement and acceptance [7].”
Landau, Z., Lebenthal, Y., Mazor‐Aronovitch, K., Brener, A., Levek, N., Jacobi‐Polishook, T., Ari, T. B., Abiri, S., Haim, A., Nir, J., et al. (2024) · Endocrine · doi:10.1007/s12020-024-03683-w · Cited by 10
Nir, J., Rachmiel, M., Fraser, A., Lebenthal, Y., Brener, A., Pinhas-Hamiel, O., Haim, A., Stern, E., Levek, N., Ben-Ari, T., et al. (2023) · Endocrine · doi:10.1007/s12020-023-03398-4 · Cited by 5
Do-It-Yourself Automated Insulin Delivery: A Position Statement
Halperin, I. J., Chambers, A., Covello, L., Farnsworth, K., Morrison, A., Schüklenk, U., Witteman, H. O., Senior, P. A., BAJAJ, H. S., Barnes, T., et al. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.05.006 · Cited by 8
A European regulatory pathway for Tidepool loop following clearance in the United States?
Downey, L., O’Donnell, S., Melvin, T., & Quigley, M. (2023) · Diabetic Medicine · doi:10.1111/dme.15246 · Cited by 8
Self-citationCrabtree, T. S. J., Choudhary, P., Lumb, A. N., Hammond, P. J., McLay, A., Campbell, F., Ng, S. M., Wilmot, E. G., & Hussain, S. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01203-5 · Cited by 7
“and on-going evolution of patient-driven innovations in diabetes technologies, it seems likely that OS-AID systems will continue to feature at some level [6].”
BackgroundResi, V., Bianchi, C., Burlina, S., Grancini, V., Manicardi, E., Masulli, M., Scarpitta, A. M., Sorice, G. P., & Fresa, R. (2025) · Acta Diabetologica · doi:10.1007/s00592-025-02592-2 · Cited by 7
“The appeal is especially strong among experienced users and parents of children with diabetes, many of whom report improved glycaemic control, reduced glucose variability, better quality of life, and improved sleep [114, 115].”
Schütz, A. K., Rami-Merhar, B. M., Schütz-Fuhrmann, I., Blauensteiner, N., Baumann, P. M., Pöttler, T., & Mader, J. K. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241230106 · Cited by 6
“The reported glycemic outcomes are consistent with prior observational studies conducted on OS-AID systems 35-37 as well as the real-world for 670G. 38 These findings align with the only other study comparing the OS-AID and commercially available AID systems.”
Lei, M., Ling, P., Lin, B., Lv, J., Liu, Z., Zhou, Y., Deng, H., Yang, D., Wang, C., Yang, X., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16505 · Cited by 5
Morrison, A., Senior, P. A., Bubela, T. M., Farnsworth, K., Witteman, H. O., & Lam, A. P. (2022) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2022.06.003 · Cited by 6
Diabetes Technology Meeting 2023
Tian, T., Aaron, R. E., DuNova, A. Y., JENDLE, J. H., Kerr, D. E., Cengiz, E., Drincic, A., Pickup, J. C., Chen, K. Y., Schwartz, N., et al. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241235205 · Cited by 7
The Latest Trends in the Management of Type 1 and Type 2 Diabetes Mellitus
DeClue, C. E., Gonzalez, M., Bradley, A. B., Leon, B. G. C., & Srivastava, G. (2024) · Endocrines · doi:10.3390/endocrines5040041 · Cited by 6
Morrison, A., Chong, K., Lai, V., Farnsworth, K., Senior, P. A., & Lam, A. P. (2022) · JMIR Diabetes · doi:10.2196/40326 · Cited by 4
“Users are actively involved in optimizing glycemia with the aims of preventing diabetes-related morbidity, increasing life expectancy, and improving sleep quality [12].”
BackgroundMethodInfluentialClosed loop insulin delivery–Opportunities and limitations
Weiss, R. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13490 · Cited by 4
Vallis, M., & Holt, R. I. G. (2022) · Diabetic Medicine · doi:10.1111/dme.14797 · Cited by 4
Schipp, J., Skinner, T. C., Holloway, E., Scibilia, R., Langstrup, H., Speight, J., & Hendrieckx, C. (2022) · PubMed · doi:10.1111/dme.14708 · Cited by 3
Self-citationCooper, D., Reinhold, B., Shahid, A., & Lewis, D. M. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231198871 · Cited by 4
“17 Additional work leveraging comparisons or combinations of these data sets should continue to pay close attention to the cleaning and use of these variables in analyses.”
Self-citationCleal, B. R., Chen, Y., Wäldchen, M., Ballhausen, H., Cooper, D., O’Donnell, S., Knoll, C., Krug, N., Raile, K., Ubben, T., et al. (2024) · Journal of Medical Internet Research · doi:10.2196/48406 · Cited by 5
“For the most part, participants reported marked improvements in physical health in accordance with the measures traditionally used to gauge this in T1D, such as HbA 1c and time in range, as reported elsewhere [15].”
Self-citationPerceived Penalties for Sharing Patient Beliefs with Health Care Providers
Marsh, J. K., Asan, O., & Kleinberg, S. (2024) · Medical Decision Making · doi:10.1177/0272989x241262241 · Cited by 2
“While patients possess unique knowledge of their own health, 10,11 their knowledge may be incomplete or incorrect.”
BackgroundDoing Your Own Patient Activist Research
McKenna, R. (2026) · Social Epistemology · doi:10.1080/02691728.2026.2646178 · Cited by 2
#We are not waiting - DIY APS Do-It-Yourself Artificial Pancreas Systems: The story so far
Crabtree, T. S. J., Ryder, B., & Wilmot, E. G. (2022) · British Journal of Diabetes · doi:10.15277/bjd.2022.373 · Cited by 3
Forlenza, G. P., Tabatabai, I., & Lewis, D. M. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0073 · Cited by 3
Self-citationLooping for (Self)Care—Personal Digital Health Technology and Algorithmic Systems
Langstrup, H., & Jansky, B. (2024) · Springer eBooks · doi:10.1007/978-3-031-52049-5_9 · Cited by 3
Self-citationPrefiguring Healthcare: Community-Driven Digital Therapeutics and the Politics of Patient Innovation
Rocha-Gomes, J. R. (2026) · Palgrave studies in environmental transformation, transition and accountability · doi:10.1007/978-3-032-07395-2_17 · Cited by 1
den Brok, E. J., Svensson, C. H., Olsen, M. T., Dimitropoulou, N. M., van Kuijk, S. M. J., Panagiotou, M., Rahman, L. A., Proennecke, S., Mertens, P. R., Athanasopoulos, S., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70879 · Cited by 2
Morrison, A., Chong, K., Lai, V., Farnsworth, K., Senior, P. A., & Lam, A. P. (2022) · doi:10.2196/preprints.40326
Open-Source-Systeme zur automatisierten Insulinabgabe
Braune, K., Knoll, C., & Cooper, D. (2022) · Die Diabetologie · doi:10.1007/s11428-022-00955-9
“Motivation und Auswirkungen der Nutzung von Open-SourceSystemen In der DIWHY-Studie [4] wurden die Motivationen verschiedener Nutzergruppen für Nutzung eines Open-Source-AID-Systems sowie die Auswirkungen auf die psychische und körperliche Gesundheit der Personen untersucht (.”
BackgroundSelf-citationSistemi di somministrazione insulinica automatizzata open source: a che punto siamo?
Bruttomesso, D., & Boscari, F. (2023) · il Diabete · doi:10.30682/ildia2302h
Jansky, B. (2023) · Journal of Contemporary Ethnography · doi:10.1177/08912416231207648 · Cited by 1
“Loopers were engaging in this open-source endeavor all over the globe, but mainly in the global North (Braune et al. 2021).”
Open-Source-AID-Systeme (AID: automatische Insulindosierung) bei Kindern und Jugendlichen
Braune, K. (2024) · Die Diabetologie · doi:10.1007/s11428-024-01221-w
Self-citationEngaged Research and Impact Case Studies
Dorris, E., Cleere, L., & Kroll, T. (2024) · SpringerBriefs in public health · doi:10.1007/978-3-031-82080-9_3
Open source automated insulin delivery: State of play in France
Poisson, A., Vaduva, P., & Agathe, G. (2025) · Diabetes & Metabolism · doi:10.1016/j.diabet.2025.101644
44324 Digital Health Citizenship – a Spectrum from Invited to Uninvited Participation
Langstrup, H. (2025) · De Gruyter eBooks · doi:10.1515/9783111247854-024 · Cited by 1
Self-citationTransformations in Diabetes Care: Lessons From Commons‐Based, Peer‐Produced Citizen Science
O’Donnell, S., & Quigley, M. (2026) · Sociology of Health & Illness · doi:10.1111/1467-9566.70140 · Cited by 1
“A growing body of evidence has emerged showing that OS AID can lead to significant improvements in self‐reported clinical outcomes and in quality of life, and that these systems can have a transformational impact on the lived experiences of end users (Braune et al. 2021).”
Self-citationCooper, D., Ubben, T., Knoll, C., Blume, C., Neumann, W., & Braune, K. (2026) · SLEEP Advances · doi:10.1093/sleepadvances/zpag066
“…reduced diabetes distress and fear of hypo-glycemia, improved subjective sleep quality, and allowed them to sleep through the night with fewer diabetes-related disruptions or device alarms, all while maintaining an average time in glycemic range exceeding international treatment targets [ 17– 23].”
Self-citationHealth data sovereignty: pinpointing conceptual ambiguities
Timmermann, C., Atenas, J., Jansky, B., Hoof, W. V., & Ursin, F. (2026) · Frontiers in Digital Health · doi:10.3389/fdgth.2026.1820189
“A recent example of this is the global, patient-led initiative “#WeAreNotWaiting community” formed by people with diabetes to develop open-source automation algorithms for insulin delivery outside of clinical settings (77, 78).”
Lin, Q., Lin, Z., Ling, P., Ni, Y., Lei, M., Cao, Y., Yang, D., Xu, W., Deng, H., Zhou, Y., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71281
“These clinical benefits are accompanied by improvements in patient-reported outcomes, including improved quality of life and reduced fear of hypo-glycemia [15, 16].”
Lewis, D. M., Hughes, M. S., Braune, K., Cengiz, D., Akcan, T., & Lal, R. (2026) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2026.08.020
Self-citationSwann, N., van Dael, J., Langstrup, H., Barry, E., Greenhalgh, T., & Papoutsi, C. (2026) · Sociology of Health & Illness · doi:10.1111/1467-9566.70287
Self-citation
Metadata
- Authors
- Braune, K., Gajewska, K. A., Thieffry, A., Lewis, D. M., Froment, T., O'Donnell, S., Speight, J., Hendrieckx, C., Schipp, J., Skinner, T., Langstrup, H., Tappe, A., Raile, K., & Cleal, B.
- Affiliations
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Royal College of Surgeons in Ireland (IE)
- Technical University of Denmark (DK)
- University College Dublin (IE)
- Deakin University (AU)
- University of Copenhagen (DK)
- Charité – Universitätsmedizin Berlin (DE)
- Steno Diabetes Center Copenhagen (DK)
- Corresponding author
- Braune, Katarina
- ORCID
- Venue
- Journal of Medical Internet Research
- Publisher
- JMIR Publications Inc.
- Published
- 2021-06-07
- Volume
- 23
- Issue
- 6
- Pages
- e25409
- ISSN
- 1438-8871 (ISSN-L)
- PMC
- PMC8218212
- OpenAlex
- W3137200532
- Cited by
- 67
- References
- 42
- Citations by year
- 2026: 9 · 2025: 5 · 2024: 15 · 2023: 11 · 2022: 20 · 2021: 7
- FWCI
- 9.89
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Journal of Medical Internet Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- Refubium (Universitätsbibliothek der Freien Universität Berlin) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Deakin Research Online (Deakin University) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion, other-oa)
- Lenus, The Irish Health Repository (Dr Steevens Hospital Library) (submittedVersion, cc-by)
- Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver (cc-by)
- Funders
- Wellcome Trust
- Steno Diabetes Center Copenhagen (SDCC HP 2. A. Diabetes Mgmt Res)
- European Commission (HORIZON2020, 823902)
- Deakin University
- Berlin Institute of Health
- Diabetes Victoria
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- artificial pancreas, diabetes self-management, user motivation, glycemic control, HbA1c, sleep quality, pediatric diabetes, diabetes complications, diabetes technology access
- MeSH terms
- Patient Reported Outcome Measures, Adult, Child, Cross-Sectional Studies, Diabetes Mellitus, Type 1, Humans, Hypoglycemic Agents, Insulin, Insulin Infusion Systems, Motivation, Self Report
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.